Sigachi Industries Ltd
NSE: SIGACHI · Pharmaceuticals · sector
₹24.83NSE close 2026-10-26
Key numbers
Market cap₹949 cr
Price₹24.83
52w high / low₹41 / ₹17
P/E37.1xSector median 27.9x
P/B1.8xSector median 2.9x
Book value₹13.7
Dividend yield0.41%Sector median 0.48%
ROE4.5%Sector median 11.7%
ROCE5.6%Sector median 12.3%
OPM10.4%Sector median 14.0%
Debt / equity0.26xSector median 0.16x
EV/EBITDA21.6xSector median 18.6x
Interest cover2.7x
Current ratio1.44x
Sales growth 3y+16.5%Sector median +9.6%
Profit growth 3y–Sector median +13.3%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹26 cr vs borrowings ₹136 cr (FY26): borrowings are higher by ₹110 cr.
- Operating profit covered interest 2.7x in the last 12 months.
- 20.04% of the promoters' shares are pledged (7.3% of all shares).
- Promoter holding fell by 3.79 percentage points in a year, to 36.69% (2026-09-30).
- Operating cash flow was below net profit in 4 of the last 5 years (FY25, FY24, FY23, FY22).
- Net loss in 1 of the last 8 quarters.
- Revenue was higher than a year earlier in 0 of the last 4 quarters.
- Other income was 21% of net profit in the last 12 months.
- Debtor days went from 137 (FY24) to 171 (FY26).
- Dividend paid in 4 of the last 5 financial years.
- Price ₹24.83 on 2026-10-26: -39.1% from the 52-week high, +49.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹59.08 · low ₹18.09
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 125 | 139 | 128 | 128 | 110 | 117 | 122 | 121 |
| EBITDA | 17 | 33 | 29 | -97 | 12 | 5 | 15 | 17 |
| OPM % | 13.8% | 23.8% | 22.3% | -75.6% | 11.0% | 4.2% | 12.5% | 13.6% |
| Other income | 15 | 2 | 2 | 4 | 2 | 0 | 1 | 1 |
| Net profit | 22 | 21 | 13 | -100 | 11 | 0 | 8 | 7 |
| EPS (₹) | 0.66 | 0.65 | 0.36 | -2.63 | 0.28 | 0.01 | 0.20 | 0.18 |
| Revenue YoY | -11.5% | -15.9% | -4.9% | -5.4% | ||||
| Profit YoY | -50.9% | -99.1% | -41.9% | – |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 250 | 302 | 399 | 488 | 478 | 471 |
| EBITDA | 53 | 59 | 77 | 100 | -64 | 49 |
| Net profit | 40 | 44 | 57 | 70 | -82 | 25 |
| EPS (₹) | 15.44 | 14.16 | 1.81 | 2.06 | -2.14 | 0.67 |
| Revenue growth | +20.7% | +32.1% | +22.4% | -2.1% | -9.6% | |
| Profit growth | +8.7% | +31.3% | +21.7% | -217.5% | – | |
| Dividend / share (₹) | – | 1.00 | 1.00 | 0.10 | 0.10 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +16.5% | – | -9.6% |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -27.1% (2y) | -32.3% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 268 | 430 | 601 | 522 |
| Borrowings | – | 40 | 143 | 142 | 136 |
| Cash & equivalents | – | 33 | 57 | 72 | 26 |
| Total assets | – | 374 | 694 | 846 | 841 |
| Fixed assets | – | 122 | 171 | 288 | 240 |
| Capital work in progress | – | 35 | 97 | 9 | 31 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 80 | 150 | 184 | 224 |
| Inventory | – | 47 | 71 | 94 | 74 |
| Payables | – | 21 | 48 | 36 | 59 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 6 | 29 | 13 | 27 | 4 |
| Cash from investing | -63 | -92 | -161 | -93 | -53 |
| Cash from financing | 108 | 26 | 172 | 81 | 2 |
| Capex | 24 | 101 | 85 | 43 | 41 |
| Free cash flow | -18 | -72 | -72 | -16 | -37 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 16.2% | 13.3% | 11.6% | -15.7% |
| ROCE % | – | 19.0% | 13.5% | 14.1% | -11.2% |
| Debtor days | – | 97 | 137 | 137 | 171 |
| Inventory days | – | 123 | 132 | 155 | 108 |
| Payable days | – | 55 | 90 | 59 | 87 |
| Cash conversion cycle (days) | – | 165 | 179 | 233 | 192 |
| Working capital days | – | 124 | 115 | 156 | 91 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 36.69% |
| FIIs | 0.52% |
| DIIs | 0.05% |
| of which Mutual funds | 0.00% |
| Public (non-institutions) | 62.74% |
| Quarter | Feb 2025 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 44.14% | 44.14% | 44.14% | 40.48% | 39.70% | 36.69% | 36.69% | 36.69% |
| Promoter group | % |
|---|---|
| RPS Industries Private Limited | 15.02% |
| Chidambarnathan Shanmuganathan | 5.08% |
| Rabindra Prasad Sinha | 3.99% |
| Amit RAJ Sinha | 3.66% |
| Swati Sinha | 2.36% |
| Nitin RAJ Sinha | 1.67% |
| Dharani Devi Chidambaranatham | 1.67% |
| RPS Family Trust | 1.21% |
| Smita Sinha | 0.81% |
| Amit RAJ Sinha Family Trust | 0.78% |
| Sudha Sinha | 0.22% |
| Bimla Sharma | 0.12% |
| Karthika Thavamani Chidambaranatham | 0.04% |
| Bhavani Shanmugam Chidambaranathan | 0.04% |
| Karan RAJ Sinha | 0.00% |
| Public holders above 1% | % |
|---|---|
| Rakesh Yadav | 2.65% |
| Maheshwari Vijaybhai Bhavsar | 1.29% |
| Sudhir Yadav | 1.23% |
1,81,400 shareholders. Pledged: 20.04% of promoter shares.
Peers in Pharmaceuticals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹4,17,478 cr | 34.5x | 5.0x | 15.5% | 18.7% | 28.6% | +10.0% | 0.94% |
| DIVISLAB | ₹2,39,825 cr | 82.1x | 14.3x | 18.4% | 23.0% | 34.7% | +10.8% | 0.34% |
| TORNTPHARM | ₹1,53,999 cr | 72.7x | 18.4x | 27.3% | 15.1% | 32.3% | +13.3% | 0.84% |
| ZYDUSLIFE | ₹1,15,808 cr | 25.9x | 4.3x | 17.7% | 16.8% | 27.2% | +16.4% | 0.95% |
| LAURUSLABS | ₹1,11,232 cr | 101.6x | 21.0x | 22.4% | 20.8% | 28.0% | +4.1% | 0.08% |
| CIPLA | ₹1,09,464 cr | 32.5x | 3.2x | 10.3% | 13.2% | 17.7% | +7.4% | 1.18% |
| DRREDDY | ₹1,09,460 cr | 33.9x | 2.9x | 9.0% | 10.1% | 15.5% | +11.0% | 0.61% |
| MANKIND | ₹95,486 cr | 46.7x | 5.9x | 13.4% | 13.8% | 25.1% | +17.7% | 0.04% |
| AUROPHARMA | ₹91,489 cr | 24.9x | 2.4x | 10.5% | 12.8% | 20.0% | +10.6% | 0.26% |
| SIGACHI | ₹949 cr | 37.1x | 1.8x | 4.5% | 5.6% | 10.4% | +16.5% | 0.41% |
Business segments (2026-06-30)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Pharmaceuticals | ₹108 cr | 89.2% | ₹11 cr | 10.0% |
| Operational and Management | ₹13 cr | 10.8% | ₹2 cr | 17.5% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-22 | Dividend | Dividend - Re 0.10 Per Share |
| 2025-09-16 | Dividend | Dividend - Rs 0.10 Per Share |
| 2024-08-28 | Dividend | Annual General Meeting/Dividend - Re 0.10 Per Share |
| 2023-10-09 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share |
| 2023-08-31 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 2022-08-19 | Other | Annual General Meeting |
| 2022-08-02 | Dividend | Interim Dividend - Re 1 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacturing: As a leading manufacturer, Sigachi Industries specialises in excipients, APIs, vitamin-mineral blends, and food stabilizers, offering high-quality solutions that cater superior-grade products tailored to meet the requirements of various industrial sectors.
- Operations and Management: Sigachi Industries provides operations management and maintenance services for chemical process plants and related sectors, delivering efficient and reliable industrial solutions.
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Sub-industry | Pharmaceuticals |
| Symbol | SIGACHI |
| BSE code | 543389 |
| ISIN | INE0D0K01022 |
| Face value | ₹1.0 |
| Incorporated | 1989-01-11 |
| Website | www.sigachi.com |
| Plants (India / abroad) | 3 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.